Por: CBS News Health November 08, 2023
The Food and Drug Administration approved a request by Eli Lilly on Wednesday to begin marketing its tirzepatide medication, which is branded as Mounjaro for diabetes, under a new brand for weight loss as well.While Mounjaro had already been used by some patients off-label for weight loss, the new FDA approval will allow the drugmaker to begin officially selling and marketing tirzepatide — branded as Zepbound — for weight loss too.Zepbound... + full article
WPLG Local 10 USA Health November 09, 2023
A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.The U.S. Food and Drug Administration approved Eli Lilly's drug, named Zepbound. The drug, also known as tirzepatide, helped dieters lose as much... + más
Popular diabetes drug Mounjaro could be FDA-approved for weight loss this year, company says | ABC News
Lawsuit filed against makers of Ozempic, Mounjaro over claims of 'gastrointestinal side effects' | ABC News
The New York Times USA Health November 09, 2023
The Food and Drug Administration on Wednesday approved an obesity drug from the company Eli Lilly that will be a direct competitor to the wildly popular Wegovy.The drug is called tirzepatide and will be sold under the name Zepbound. It joins a class of new medications that are... + más
‘There's no way that patients are going to be able to afford that.’ Why aren’t new drugs that can help you lose weight more widely used? | MarketWatch
Los Angeles Times USA Science November 09, 2023
A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday. The U.S. Food and Drug Administration approved Eli Lilly's Zepbound, or tirzepatide. The drug helped dieters lose about a quarter of their body... + más
MarketWatch USA Business November 08, 2023
Lilly (LLY) took a direct shot at Novo on Wednesday, saying it will set a list price for Zepbound of $1,059.87 for a month’s supply, which it noted is lower than Wegovy’s list price of $1,349.02. That lower price point for Zepbound hints at a coming commercial rivalry with... + más
FDA approves a new weight loss drug, Zepbound from Eli Lilly | CBS News
As Eli Lilly Gears Up For Growth, Its CFO Prescribes Leading Indicators | Forbes
ABC7 USA Health November 08, 2023
A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.The U.S. Food and Drug Administration approved Eli Lilly's Zepbound, or tirzepatide. The drug helped dieters lose about a quarter of their body... + más
10 WBNS USA Nation November 08, 2023
WASHINGTON — A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday. The U.S. Food and Drug Administration approved Eli Lilly's Zepbound, or tirzepatide. The drug about a quarter of their body... + más
WPTV USA Nation November 08, 2023
The U.S. Food and Drug Administration , a new weight loss drug from pharmaceutical company Eli Lilly, on Wednesday. Zepbound is a once-weekly injectable medication with an active ingredient called tirzepatide. The ingredient is something the FDA previously approved for Eli... + más
What Are the Duties of A Trustee? | Forbes
Salvaged debris from Titan submersible contains 'presumed human remains': US Coast Guard | ABC News
About iurex | Privacy Policy | Disclaimer |